DSP Group and Cloud of Things Combine Forces and Introduce a Fully Managed ULE IoT Cloud Services Gateway

19

July 2021

by Arti Loftus

Ultra-Low Energy (ULE), an extension of the Digital Enhanced Cordless Telecommunications (DECT) physical layer specification that supports low power devices, is becoming an increasingly popular approach, promoted by the ULE Alliance as “a way to provide sensors, actuators and other smart devices in the Internet of Things (IoT) with two-way transmission capability over a dedicated frequency band of 1900MHz.”

Today, DSP Group (DSPG) and Cloud of Things announced that they have collaborated on a Fully Managed IoT Cloud Services gateway based on DSPG’s DHAN-M ULE module.

ULE is supported by an advanced family of low-power system-on-chip (SoC) and modular chipset products that provide greater range outdoors and superior coverage indoors, robust and secure RF channels, and a star network topology that eliminates the need for repeaters and makes it possible to connect devices at scale that run from one central hub.

Perhaps most importantly, ULE’s high bit rate can support the data and two-way voice and video required for an increasing number of applications that connect things and people. As such, it allows devices to be controlled through voice activation while also supporting the “visual” IoT and emergency two-way conversations in applications such as security and home healthcare monitoring.

Cloud of Things, a developer of solutions around its DeviceTone technology that quickly and efficiently makes products smart, announced with DSPG that they would be using the upcoming ISC West trade show in Las Vegas, NV, to demonstrate a fully managed Internet of Things (IoT) gateway based on ULE.

An enterprise-grade device, the CoT Smart IoT Gateway securely collects sensor and equipment data from the edge of the network for localized or cloud-based analysis, relying on ULE for reliable, interference-free, full-coverage wireless communications throughout the home or office.

The announcement and demonstration at ISC West come at a time of rapid growth for connected, smart products for home monitoring and security, as well as lighting, entertainment, and smart appliances.

In February 2021, Fortune Business Insights predicts the market to increase from $79.90B in 2018 to $622.59B by 2026, for a CAGR of 29.3% over the forecast period.

The increased adoption of connected devices across the home, as well as the enterprise, has created a market pull for more reliable sensor-to-hub communications in what is becoming an increasingly noisy RF environment. In addition, under pressure to meet rapidly closing time-to-market windows, product developers are looking for faster deployment options.

“This combination of market trends and customer demand is why we are excited Cloud of Things chose our ULE solution as the wireless interface for the CoT IoT Gateway, and we look forward to demonstrating its capabilities at ISC West,” said Tali Chen, Chief Business Officer (CBO) at DSP Group. “The reliable transmission of wireless data is essential if advanced IoT, machine learning, and artificial intelligence techniques are to reach their full potential at the edge, particularly for critical applications such as home healthcare and security,” said Chen. “By incorporating our DHAN-M ULE module in its Gateway, Cloud of Things is making enormous strides in this direction.”

Along with DSP Group’s highly integrated, fully certified DHAN-M ULE module, the Gateway features a fanless design, uses an embedded OpenWRT OS, has a Secure U-Boot boot loader, fail-safe FOTA, and two Ethernet ports, as well as Wi-Fi connectivity, all in a box measuring 82 x 82 x 30 mm, and weighing only 220 grams.

“ULE adds reliable, interference-free operation, wide-coverage, low power, and high quality-of-service (QoS),” said Avner Ziv, CEO at Cloud of Things. “Together with our integrated suite of DeviceTone services, we can now offer developers a simplified connected product development cycle and faster time-to-market for scalable IoT sensor networks for cloud application services across the smart home or office.”

Originally published on IoT Evolution World

Similar Blogs

Advancing Plant-Based Pharma like Cannabis with Sensors and IoT Platform

Advancing Plant-Based Pharma like Cannabis with Sensors and IoT Platform

Plant-based biologics is seen by many experts in the bio-pharmaceutical industry to be the next major commercial development in the field of biotechnology. Advantages include the opportunity to produce safer drugs at lower costs when the cultivating of the plant source is of the highest quality, grown efficiently, harvested, and processed in a timely way, and distributed through reliable supply chains.

read more
Hortica Comes out of Stealth Mode to Reveal Connected Cultivation Greenhouse for Medical Cannabis Leveraging Edge Compute and Advanced Automation

Hortica Comes out of Stealth Mode to Reveal Connected Cultivation Greenhouse for Medical Cannabis Leveraging Edge Compute and Advanced Automation

After years of development and testing, one of Israel’s most interesting AGTech startups, Hortica, announced this week they are coming to America to build connected, automated, large-scale precision growth facilities that have proven to produce the highest quality cannabis for medical products.

read more
As global demand for high-quality medical cannabis skyrockets, Hortica, Cloud of Things, and AES announce innovative cultivation initiative

As global demand for high-quality medical cannabis skyrockets, Hortica, Cloud of Things, and AES announce innovative cultivation initiative

Hortica, a technology-oriented company that is developing and manufacturing an advanced platform for cultivating plant-made pharmaceuticals today announced it has selected Cloud of Things and AES to partner on a major innovation initiative that will accelerate the implementation of Hortica’s breakthrough which makes it possible for growers of cannabis and of other medicinal plants to supply organic, safe, consistent and standardized crops to patients, clinical trials and pharmaceutical industry.

read more
Let's chat ...